Form: 10-K

Annual report pursuant to Section 13 and 15(d)

March 27, 2024

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statements on Form S-1 (File Nos. 333-208638, 333-214198, 333-214310, 333-221468, 333-225675, 333-231888, 333-238132, and 333-268554), Form S-1 MEF (File Nos. 333-226374 and 333-238892), Form S-3 (File Nos. 333-208189, 333-252309, and 333-274880), and Form S-8 (File Nos. 333-164398, 333-195255, 333-221469, 333-233460, and 333-266594) of Cellectar Biosciences, Inc. of our report dated March 27, 2024, relating to the consolidated financial statements which appears in this annual report on Form 10-K for the year ended December 31, 2023.

/s/ Baker Tilly US, LLP

Madison, Wisconsin

March 27, 2024